Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Sold by Cerity Partners LLC

Cerity Partners LLC trimmed its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 8.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,112 shares of the company’s stock after selling 4,261 shares during the quarter. Cerity Partners LLC owned 0.09% of Nu Skin Enterprises worth $896,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. CWM LLC lifted its position in shares of Nu Skin Enterprises by 5,838.9% during the 3rd quarter. CWM LLC now owns 2,138 shares of the company’s stock worth $45,000 after purchasing an additional 2,102 shares during the last quarter. Signaturefd LLC lifted its position in Nu Skin Enterprises by 240.7% in the third quarter. Signaturefd LLC now owns 3,996 shares of the company’s stock valued at $85,000 after acquiring an additional 2,823 shares during the last quarter. Counterpoint Mutual Funds LLC acquired a new position in Nu Skin Enterprises in the third quarter valued at $124,000. PNC Financial Services Group Inc. increased its position in shares of Nu Skin Enterprises by 211.5% during the third quarter. PNC Financial Services Group Inc. now owns 7,986 shares of the company’s stock worth $169,000 after purchasing an additional 5,422 shares in the last quarter. Finally, Gladius Capital Management LP acquired a new stake in shares of Nu Skin Enterprises in the 3rd quarter valued at about $178,000. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Trading Down 2.8 %

Shares of NUS stock opened at $12.64 on Tuesday. Nu Skin Enterprises, Inc. has a twelve month low of $11.84 and a twelve month high of $41.50. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. The business’s 50 day moving average is $12.99 and its two-hundred day moving average is $16.46. The company has a market capitalization of $624.68 million, a P/E ratio of 70.22 and a beta of 1.11.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.08. Nu Skin Enterprises had a net margin of 0.44% and a return on equity of 10.73%. The company had revenue of $488.64 million for the quarter, compared to analysts’ expectations of $479.35 million. Equities analysts forecast that Nu Skin Enterprises, Inc. will post 1.13 EPS for the current year.

Nu Skin Enterprises Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were issued a $0.06 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $0.24 annualized dividend and a dividend yield of 1.90%. Nu Skin Enterprises’s dividend payout ratio is currently 133.33%.

Insider Activity at Nu Skin Enterprises

In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the firm’s stock in a transaction on Thursday, January 25th. The stock was sold at an average price of $18.55, for a total value of $37,100.00. Following the completion of the sale, the director now owns 31,225 shares of the company’s stock, valued at $579,223.75. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders have sold a total of 6,000 shares of company stock worth $86,660 over the last three months. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on NUS. DA Davidson reduced their price objective on Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 5th. StockNews.com cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $23.67.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.